| 2025 | | Real-world treatment outcomes in South Korean patients with epidermal growth factor receptor-mutant non-small cell lung cancer
The Korean journal of internal medicine, 40(6). : 1029-1041, 2025 | 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 2025 | | Analysis of outcomes according to start timing of adjuvant chemotherapy in patients with gastric cancer: a retrospective nationwide cohort study
The oncologist, 30(6). : oyaf132-oyaf132, 2025 | 강석윤, 권민석, 김태환, 박범희, 안미선, 이현우, 최용원, 최진혁 |
| 2025 | | Delayed central nervous system progression with atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer (LU23-15)
Lung cancer (Amsterdam, Netherlands), 201. : 108455-108455, 2025 | 김태환, 최진혁 |
| 2024 | | Clinical application of whole-genome sequencing of solid tumors for precision oncology
Experimental & molecular medicine, 56(8). : 1856-1868, 2024 | 강석윤, 고영화, 곽규성, 권민석, 김석휘, 김선일, 김세혁, 김장희, 김재근, 김창우, 김철호, 김태환, 노성현, 노진, 노충균, 박지원, 박지은, 백수연, 손상용, 신승수, 안미선, 양민재, 유우식, 윤재성, 이기명, 이길호, 이다근, 이현우, 임선교, 장전엽, 정윤정, 조대성, 최용원, 최진혁, 하태양, 한상욱, 허지미, 허훈 |
| 2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study
BMC cancer, 24(1). : 70-70, 2024 | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2024 | | Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
Cancer research and treatment, 56(1). : 48-60, 2024 | 최진혁 |
| 2023 | | Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study
Gastric cancer, 26(6). : 1012-1019, 2023 | 강석윤, 권민석, 김태환, 손상용, 신승수, 안미선, 이현우, 최용원, 최진혁, 한상욱, 허훈 |
| 2023 | | Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial
Journal of thoracic oncology, 18(9). : 1209-1221, 2023 | 최진혁 |
| 2023 | | Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
Cancers, 15(2). : 471-471, 2023 | 최진혁 |
| 2022 | | Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)
Cancer research and treatment, 54(1). : 109-117, 2022 | 최진혁 |
| 2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study
The Korean journal of internal medicine, 37(2). : 434-443, 2022 | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
| 2022 | | Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
The Korean journal of internal medicine, 37(6). : 1269-1269, 2022 | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2022 | | Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
The Korean journal of internal medicine, 37(3). : 653-659, 2022 | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2022 | | Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)
The Korean journal of internal medicine, 37(1). : 190-200, 2022 | 최진혁 |
| 2022 | | Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study
BMC cancer, 22(1). : 948-948, 2022 | 강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data
Scientific reports, 12(1). : 7646-7646, 2022 | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2021 | | Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
BMC cancer, 21(1). : 325-325, 2021 | 강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁 |
| 2021 | | PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
Journal of clinical oncology, 39(26). : 2903-2913, 2021 | 최진혁 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia
Annals of hematology, 100(11). : 2825-2830, 2021 | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 2021 | | Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer
Frontiers in oncology, 10. : 558760-558760, 2021 | 강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁 |
| 2021 | | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
British journal of cancer, 124(4). : 713-720, 2021 | 최진혁 |
| 2020 | | Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)
BMC cancer, 20(1). : 813-813, 2020 | 최진혁 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer
BMC cancer, 20(1). : 167-167, 2020 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2019 | | Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?
Journal of clinical oncology, 37(15_suppl). : e20616-e20616, 2019 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2019 | | Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer
Cancer research and treatment, 51(1). : 119-127, 2019 | 최진혁 |
| 2019 | | The role of surgical resection before palliative chemotherapy in advanced gastric cancer
Scientific reports, 9. : 4136-4136, 2019 | 강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈 |
| 2018 | | Should combination chemotherapy be used in all advanced gastric cancer patients?
Journal of clinical oncology, 36(15S). : e16081-e16081, 2018 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2018 | | Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy
Journal of clinical oncology, 36(15S). : e16008-e16008, 2018 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2018 | | P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
Journal of thoracic oncology, 13(10S). : S790-S791, 2018 | 최진혁 |
| 2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis
Cancer research, 78(13S). : 469-469, 2018 | 강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
American journal of clinical oncology, 41(4). : 385-390, 2018 | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2018 | | Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma
Leukemia & lymphoma, 59(11). : 2670-2678, 2018 | 강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2018 | | The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis
Medicine, 97(39). : e12588-e12588, 2018 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
The Korean journal of internal medicine, 32(3). : 422-428, 2017 | 최용원, 최진혁 |
| 2017 | | Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes
Cancer research and treatment, 49(2). : 484-493, 2017 | 강석윤, 임현이, 전미선, 정용식, 최진혁, 한세환 |
| 2016 | | The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer
Medicine, 95(5). : e2772-e2772, 2016 | 박광주, 안영실, 오영택, 윤준기, 이수진, 최진혁 |
| 2016 | | Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer
International journal of radiation oncology, biology, physics, 94(3). : 621-627, 2016 | 노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성 |
| 2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy
International journal of hematology, 103(2). : 210-218, 2016 | 강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments
PloS one, 11(9). : e0163748-e0163748, 2016 | 강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환 |
| 2016 | | Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer
Scientific reports, 6. : 38585-38585, 2016 | 고영화, 안미선, 이현우, 최용원, 최진혁 |
| 2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
Lung cancer (Amsterdam, Netherlands), 93. : 1-8, 2016 | 강석윤, 최진혁 |
| 2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.
Journal of Korean medical science, 30(10). : 1416-1422, 2015 | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands), 87(2). : 155-161, 2015 | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
| 2015 | | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.
Journal of clinical oncology, 33(24). : 2660-2666, 2015 | 최진혁 |
| 2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?
Acta oncologica (Stockholm, Sweden), 54(8). : 1231-1234, 2015 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
| 2014 | | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
The Lancet. Oncology, 15(12). : 1389-1396, 2014 | 최진혁 |
| 2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Journal of Korean medical science, 29(11). : 1493-1500, 2014 | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia.
International journal of laboratory hematology, 36(1). : e20-e23, 2014 | 강석윤, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
| 2013 | | Four Cases of Metastasectomy for Pulmonary Metastasis of Nasopharyngeal Carcinoma
The Korean journal of medicine, 84(1). : 135-140, 2013 | 선주성, 안미선, 최진혁, 최호, 한재호 |
| 2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Onkologie, 36(7-8). : 421-426, 2013 | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
